The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial
The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial
复制标题
使用利培酮预防 ERCP 后胰腺炎的东京试验 (Tokyo P3R) 的结果：一项多中心、随机、II 期、非安慰剂对照试验
作者：
Tsujino T;Isayama H;Nakai Y;Ito Y;Togawa O;Toda N;Arizumi T;Kogure H;Yamamoto K;Mizuno S;Yashima Y;Yagioka H;Sasaki T;Matsubara S;Yamamoto N;Hirano K;Sasahira N;Tada M;Koike K
